When someone is diagnosed with renal cell carcinoma (RCC), one of the first questions may be whether chemotherapy is required.

For the most common forms of RCC, particularly clear cell renal cell carcinoma, conventional chemotherapy is generally not the main treatment because these cancers usually respond poorly to standard chemotherapy drugs. Modern treatment for advanced RCC more commonly involves immunotherapy, targeted therapy or combinations of these treatments.

However, chemotherapy can have a role in selected uncommon types of renal cancer, so the term “kidney cancer” should not be treated as a single disease.

The appropriate treatment depends on the cancer subtype, stage, tumor characteristics, whether it has spread, kidney function and the patient's overall health.

At Prabhakar Bhurke Clinic, Dr. Sandip Prabhakar Bhurke, super specialist nephrologist and transplant physician, provides kidney-focused evaluation and helps coordinate appropriate care for patients with complex kidney conditions, including kidney-function issues associated with cancer and its treatment.

What Is Renal Cell Carcinoma?

Renal cell carcinoma is a cancer that develops in the kidney.

There are several pathological subtypes of RCC. Clear cell RCC is the most common, while papillary, chromophobe and several less common forms represent other types.

The exact subtype matters because kidney cancers do not all behave in the same way or respond to the same medicines.

Cancer evaluation may therefore involve:

• Imaging studies

• Kidney-function testing

• Assessment of tumor characteristics

• Pathology or biopsy in selected cases

• Evaluation for spread to other organs

• Review of the patient's overall health

The treatment team uses this information to determine the most appropriate strategy.

Why Conventional Chemotherapy Is Usually Not the First Choice for RCC

Traditional chemotherapy works by attacking rapidly dividing cells.

However, common RCC, including clear cell RCC, generally has limited sensitivity to conventional chemotherapy. As a result, standard chemotherapy is not routinely used as the primary systemic treatment for most patients with these cancers.

Instead, modern systemic treatment may use medicines that:

• Stimulate the immune system to attack cancer

• Block pathways that help cancer cells grow

• Interfere with blood-vessel formation supporting the tumor

• Target specific biological mechanisms involved in cancer growth

This is why a treatment plan for advanced RCC may look very different from chemotherapy used for cancers such as some lymphomas, breast cancers or gastrointestinal cancers.

When Can Chemotherapy Be Considered for Kidney Cancer?

Although conventional chemotherapy is not commonly used for typical clear cell RCC, some rare kidney cancer subtypes may respond to chemotherapy.

For example, chemotherapy can be considered for certain uncommon cancers such as:

• Collecting duct carcinoma

• Renal medullary carcinoma

• Selected other non-clear-cell renal malignancies

Depending on the cancer subtype, platinum-based combinations may be considered by the oncology team.

Therefore, the question should not simply be “Does kidney cancer need chemotherapy?”

A more useful question is:

“What type of renal cell carcinoma does the patient have, and which treatment has the best evidence for that specific cancer?”

What Treatments Are Commonly Used Instead of Chemotherapy?

For many patients with RCC, especially advanced disease, doctors may consider immunotherapy and targeted therapy.

Immunotherapy

Immunotherapy helps the immune system recognize and attack cancer cells.

Immune checkpoint inhibitors used in RCC include medicines such as:

• Pembrolizumab

• Nivolumab

• Ipilimumab

Combination immunotherapy may be used in selected patients with advanced RCC.

Targeted Therapy

Targeted medicines interfere with biological pathways that cancer cells use to grow or survive.

Depending on the clinical situation, targeted treatments may include drugs such as:

• Axitinib

• Cabozantinib

• Lenvatinib

• Pazopanib

• Sunitinib

• Tivozanib

• Everolimus

• Belzutifan in selected advanced clear cell RCC settings

The choice depends on the cancer subtype, previous treatment, risk profile, treatment response and other clinical factors.

Is Surgery Still Important in Renal Cell Carcinoma?

Yes.

For localized RCC, surgery is often an important part of treatment.

Depending on the tumor's size, location and the patient's kidney function, the surgeon may consider:

Partial Nephrectomy

Only the tumor and a margin of surrounding kidney tissue are removed when this can be done safely.

Preserving functioning kidney tissue can be particularly important when kidney function is already reduced or the patient has risk factors for future kidney disease.

Radical Nephrectomy

The entire affected kidney is removed.

This may be necessary for certain larger, centrally located or otherwise unsuitable tumors.

The decision between partial and radical nephrectomy requires careful assessment of both cancer control and remaining kidney function.

What Happens When Renal Cell Carcinoma Has Spread?

When RCC has metastasized to other parts of the body, treatment often relies more heavily on systemic therapies.

Depending on the cancer's characteristics and the patient's risk category, treatment may include combinations such as:

• Immunotherapy plus immunotherapy

• Immunotherapy plus targeted therapy

• Targeted therapy

• Other systemic medicines after previous treatments

Current treatment options for advanced RCC include several immunotherapy and targeted-treatment combinations.

In selected patients, surgery may also have a role.

Treatment decisions are individualized rather than based solely on the fact that the cancer is stage IV.

What Is the Role of Kidney Function During Cancer Treatment?

Kidney function is particularly important when treating a patient with renal cell carcinoma.

Doctors may monitor:

• Serum creatinine

• eGFR

• Electrolytes

• Blood pressure

• Urine protein

• Fluid balance

• The function of the remaining kidney after nephrectomy

A patient who has had one kidney removed does not automatically develop kidney failure. Many people can maintain adequate kidney function with one functioning kidney, but long-term monitoring is important.

Patients with pre-existing CKD require additional attention to medication selection, hydration, blood pressure and other kidney-related factors.

Can Cancer Treatment Affect Kidney Function?

Yes.

Kidney function can be affected by several factors during cancer care, including:

• Certain anticancer medicines

• Dehydration

• Infection

• Low blood pressure

• Contrast exposure in selected circumstances

• Urinary obstruction

• Other acute illnesses

Some immunotherapies can cause immune-related kidney inflammation, although this is not the most common complication.

A rising creatinine during cancer treatment should therefore be evaluated rather than automatically attributed to cancer progression or assumed to be permanent kidney failure.

What Are Possible Side Effects of Chemotherapy?

When conventional chemotherapy is used for a specific kidney cancer subtype, side effects depend on the medicines selected.

Possible effects include:

• Fatigue

• Nausea

• Vomiting

• Reduced appetite

• Mouth sores

• Diarrhea or constipation

• Hair loss

• Lower blood-cell counts

• Increased risk of infection

• Easy bruising or bleeding

• Nerve-related symptoms with certain drugs

For example, platinum-based chemotherapy can cause particular toxicities, including effects on nerves and blood counts.

The treating oncologist should explain the expected side effects of the specific regimen.

What Are the Side Effects of Immunotherapy?

Immunotherapy works differently from conventional chemotherapy.

Because it activates or modifies immune responses, it can sometimes cause the immune system to attack normal organs.

Potential immune-related effects may involve:

• Skin

• Thyroid

• Liver

• Colon

• Lungs

• Kidneys

• Other organs

Symptoms and severity vary.

Any new or unexplained symptom during immunotherapy should be reported promptly to the oncology team.

What Are the Side Effects of Targeted Therapy?

Targeted drugs also have their own safety profiles.

Depending on the medicine, possible effects can include:

• High blood pressure

• Diarrhea

• Fatigue

• Reduced appetite

• Hand-foot skin reactions

• Mouth sores

• Liver-test abnormalities

• Changes in thyroid function

• Other treatment-specific effects

Regular monitoring allows the cancer team to identify complications and adjust treatment when necessary.

Does Renal Cell Carcinoma Treatment Always Require Chemotherapy?

No.

A patient diagnosed with RCC should not assume that chemotherapy is automatically required.

For many common RCC cases, treatment may involve:

• Surgery

• Active surveillance for selected small tumors

• Ablation or other local treatment in selected patients

• Immunotherapy

• Targeted therapy

• Combination systemic treatment

• Clinical trials

The appropriate approach depends on the stage, subtype, tumor characteristics and overall health.

What Tests Help Plan RCC Treatment?

Before choosing treatment, doctors may evaluate:

Imaging

Depending on the situation, imaging may include:

• Ultrasound

• CT scan

• MRI

• Chest imaging

• Other scans for suspected metastatic disease

Laboratory Tests

Blood testing may assess:

• Kidney function

• Blood counts

• Liver function

• Electrolytes

• Other treatment-related parameters

Pathology

When tissue is available, pathology helps establish the cancer type and relevant characteristics.

Overall Health Assessment

Age, cardiovascular health, kidney function, previous treatments and other medical conditions may influence the treatment plan.

Can Kidney Cancer Treatment Be Given if Kidney Function Is Poor?

Sometimes, yes, but the treatment plan may need additional individualization.

A person with CKD, one functioning kidney, dialysis dependence or previous nephrectomy may require careful assessment before starting cancer treatment.

The oncology and nephrology teams may work together to:

• Review current eGFR

• Identify potentially kidney-toxic medicines

• Adjust medication doses when necessary

• Monitor electrolytes

• Manage blood pressure

• Address fluid balance

• Investigate changes in creatinine promptly

This coordinated approach is especially important when both cancer and kidney disease are present.

What Is Onconephrology?

Onconephrology is the area of kidney care focused on patients with cancer.

It addresses kidney-related issues such as:

• Acute kidney injury during cancer treatment

• CKD in cancer patients

• Electrolyte abnormalities

• Proteinuria

• High blood pressure

• Kidney effects of anticancer medicines

• Fluid and acid-base problems

• Dialysis when required

For patients with RCC and significant kidney-function concerns, collaboration between oncology, urology and nephrology can help coordinate treatment.

Can Dialysis Be Needed During Renal Cell Carcinoma Treatment?

Dialysis is not automatically required because someone has kidney cancer.

However, a patient with severe acute kidney injury or advanced kidney failure may occasionally require kidney replacement therapy.

Possible reasons can include:

• Severe fluid overload

• Persistent dangerous potassium elevation

• Severe metabolic acidosis

• Significant uremic complications

• Severe kidney dysfunction from another underlying cause

The decision is based on the patient's overall clinical condition rather than the cancer diagnosis alone.

Why Is Kidney Preservation Important After Nephrectomy?

If one kidney is removed, the remaining kidney becomes especially important for long-term health.

Kidney-protective care may include:

• Monitoring creatinine and eGFR

• Managing blood pressure

• Controlling diabetes when present

• Avoiding unnecessary kidney-harming medicines

• Monitoring urine albumin when appropriate

• Maintaining an individualized diet

• Following recommended medical reviews

The goal is to preserve the function of the remaining kidney while continuing appropriate cancer surveillance.

What Happens After Renal Cell Carcinoma Treatment?

Follow-up depends on the cancer stage and treatment.

Monitoring may include:

• Periodic imaging

• Kidney-function testing

• Blood tests

• Assessment for treatment-related complications

• Monitoring for recurrence

• Management of long-term kidney health

The exact follow-up schedule is determined by the cancer-care team.

When Should a Kidney Specialist Be Involved?

Nephrology input may be useful when a patient with RCC has:

• Reduced eGFR

• Rising creatinine

• Proteinuria

• A single functioning kidney with declining function

• Acute kidney injury

• Electrolyte abnormalities

• Significant hypertension

• Dialysis dependence

• Kidney-related complications during cancer therapy

The nephrologist's role is to protect kidney function while the oncology and urology teams focus on cancer treatment.

Renal Cell Carcinoma and Kidney Care at Prabhakar Bhurke Clinic

At Prabhakar Bhurke Clinic, Dr. Sandip Prabhakar Bhurke, super specialist nephrologist and transplant physician, provides specialist evaluation for patients with kidney-function concerns associated with cancer and cancer treatment.

Depending on the patient's needs, kidney-focused care may include:

• Baseline kidney-function assessment

• Creatinine and eGFR monitoring

• Proteinuria evaluation

• Electrolyte management

• Blood-pressure management

• Assessment of acute kidney injury

• Kidney care after nephrectomy

• Evaluation of kidney complications during systemic cancer treatment

• Dialysis-related kidney care when indicated

• Coordination with oncology and urology teams

Cancer treatment should be planned by the appropriate oncology and urology specialists, with nephrology involvement when kidney health requires additional attention.

Frequently Asked Questions

Is chemotherapy effective for renal cell carcinoma?

Conventional chemotherapy generally has limited effectiveness against common RCC, especially clear cell RCC, and is not usually the main treatment. Selected rare kidney cancer subtypes may respond to chemotherapy.

What is usually used instead of chemotherapy for advanced RCC?

Advanced RCC is commonly treated with immunotherapy, targeted therapy or combinations of these approaches, depending on the cancer subtype and patient's clinical situation.

Does renal cell carcinoma require surgery?

Localized RCC is often treated with surgery, which may involve partial or radical nephrectomy depending on tumor and patient factors. Some small tumors may be suitable for active surveillance or other local treatments.

Can RCC treatment affect kidney function?

Yes. Kidney function can be influenced by surgery, medications, dehydration, infection, obstruction and other treatment-related or disease-related factors. Regular monitoring is important.

Is immunotherapy the same as chemotherapy?

No. Immunotherapy works by modifying the immune response against cancer, whereas conventional chemotherapy uses cytotoxic drugs that target rapidly dividing cells.

Can a person with kidney disease receive cancer treatment?

Potentially, yes. Treatment must be individualized according to kidney function, cancer type, other medical conditions and the specific treatment being considered.

Can dialysis patients receive treatment for renal cell carcinoma?

Some dialysis patients can receive cancer treatment, but therapy requires careful coordination among oncology, urology and nephrology teams.

Conclusion

Renal cell carcinoma chemotherapy is not the standard treatment for most common forms of kidney cancer. Clear cell RCC and several other common RCC types generally respond poorly to conventional chemotherapy, so modern treatment often relies on surgery for localized disease and immunotherapy, targeted therapy or combinations for advanced disease.

Chemotherapy may still have a role in selected rare renal cancer subtypes. Therefore, treatment decisions should be based on the exact pathology, cancer stage, kidney function and overall health rather than the general label of “kidney cancer.”

When RCC occurs alongside reduced kidney function, nephrology involvement can be valuable for monitoring creatinine, eGFR, electrolytes, blood pressure and other kidney-related complications during treatment.

For individualized kidney-function assessment and specialist nephrology care, consult Dr. Sandip Prabhakar Bhurke at Prabhakar Bhurke Clinic.

Medical Disclaimer

This article is intended for general educational and informational purposes only and should not be considered a substitute for cancer diagnosis, treatment or individualized medical advice. Renal cell carcinoma includes different cancer subtypes, and treatment varies according to pathology, stage, tumor characteristics, kidney function and overall health. Conventional chemotherapy is not the primary treatment for most common RCC, but selected rare kidney cancer subtypes may be treated with chemotherapy. Immunotherapy, targeted therapy, surgery and other treatments may be appropriate depending on the individual case. Do not start, stop or change cancer medicines, kidney medicines, supplements or dialysis treatment based solely on this article. Any rise in creatinine or new symptoms during cancer treatment should be promptly discussed with the treating medical team. Consult the appropriate oncologist, urologist and nephrologist for an individualized treatment plan.